Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
SLNO
SLNO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SLNO News
Brookfield to Acquire Peakstone Realty Trust for $1.2 Billion
Feb 02 2026
Benzinga
Soleno Therapeutics Under Investigation for Securities Violations Amid 40% Stock Decline
Jan 20 2026
Globenewswire
Soleno Therapeutics Under Investigation, Shares Plunge 26.59%
Jan 17 2026
Globenewswire
Soleno Therapeutics (SLNO) Shares Plunge 28% Following VYKAT™ XR Disappointment
Jan 16 2026
Globenewswire
Soleno Therapeutics Shares Drop 26.59% Following Safety Concerns Over Vykat XR
Jan 12 2026
Businesswire
Soleno Therapeutics Faces Investigation After Vykat XR Price Drop of 26.59%
Jan 09 2026
Globenewswire
Bragar Eagel & Squire Investigates Soleno, Avita, and Coty for Potential Securities Violations
Jan 08 2026
Globenewswire
Soleno Therapeutics Faces Investigation Over Vykat XR Safety Claims, Stock Plummets 26.59%
Jan 06 2026
Globenewswire
Soleno Therapeutics Faces Investigation Over Vykat XR, Stock Plummets 26.59%
Jan 01 2026
PRnewswire
Soleno Therapeutics Faces Investigation After Vykat XR Price Drop of 26.59%
Dec 31 2025
Businesswire
Soleno Therapeutics Faces Investigation After Vykat XR Price Drop of 26.59%
Dec 31 2025
Newsfilter
Soleno Therapeutics Faces Investigation Over Vykat XR Issues, Stock Plummets 26.59%
Dec 30 2025
Globenewswire
Soleno Therapeutics Faces Investigation Over VYKAT™ XR Misstatements as Stock Plummets 40%
Dec 16 2025
PRnewswire
Rhythm Pharma Hits the Right Note with Promising Early Results from PWS Trial
Dec 11 2025
Benzinga
Soleno Therapeutics Faces Investigation Over Vykat XR Safety Claims, Stock Plummets 26.59%
Dec 11 2025
PRnewswire
Soleno Therapeutics Faces Investigation Over VYKAT™ XR Misstatements as Stock Plummets 40%
Dec 04 2025
PRnewswire
Show More News
